CVS Health stock price rises

What's Going On With CVS Health Stock?
CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks are trading lower in possible reaction to UnitedHealth's quarterly revenue miss.
CVS Health Corp. stock rises Wednesday, still underperforms market
Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.83% to 5,949.91 and the Dow Jones Industrial Average DJIA rising 1.
After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?
CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in 2024, when its shares nose-dived by 43%.
Wells Fargo Reaffirms Their Buy Rating on CVS Health (CVS)
Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on January 10 and set a price target of
CVS Health Corp. stock rises Tuesday, still underperforms market
Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 5,842.
What You Need To Know Ahead of CVS Health's Earnings Release
With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide range of health solutions in the United States. With offerings that span pharmacy benefit management,
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
CVS Health stock price rises after Walgreens earnings: is it a buy?
The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the strong Walgreens Boots Alliance earnings, which pushed the stock up almost 50% from its lowest point in 2024.
CVS Health Isn't Going To The Dogs
CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.
Hosted on MSN2h
CVS anti-theft measures hurting profits
Tough times for retailers, who have battled out-of-control shoplifting and now say they’re losing money because of anti-theft ...
Popular fitness center to move into former CVS location in Worcester
Planet Fitness will be part of the Mercantile Center, a mixed-use property located downtown that includes 90 Front St., ...
CVS sells now-shuttered San Jose store for $9.25M
CVS operates 25 sites in San Jose, with another one roughly two miles from the recently sold site. The 5407 Camden Ave.
UnitedHealth, CVS Health made top picks at Piper Sandler on Medicare rating proposal
Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...
Healthcare Dive8d
CVS successfully converts commercial pharmacy contracts to “cost plus” model
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
Suspect arrested for armed robbery at CVS in Merced, police say
MERCED, Calif. (KFSN) -- A man has been arrested after an armed robbery at a business in Merced over the weekend. Sunday ...
Yahoo Finance2d
CVS Health Corporation (CVS)
CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.
Why CVS Health (CVS) Led the Monday Upsurge?
We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...